India’s insurance sector is expected to report mixed performance in the September quarter, as healthy demand for life insurance products contrasts with profitability pressures in general insurance. Brokerages have identified the Insurance Regulatory and Development Authority of India’s proposed changes to commission structures and expense of management norms as a key monitorable, given their potential implications for distribution economics, operating costs and insurer margins.

Among life insurers, ICICI Prudential Life Insurance is expected to lead large private sector peers in annualised premium equivalent growth, with Emkay Research projecting an increase of approximately 18 percent year on year. SBI Life Insurance is expected to report growth of around 11 percent, followed by HDFC Life Insurance at 9 percent and Axis Max Life at 8 percent.

Emkay expects a favourable shift towards non participating savings plans and term protection products, alongside higher rider attachment, to support value of new business margins. ICICI Prudential Life Insurance and Life Insurance Corporation of India are expected to record healthier margin expansion, while SBI Life Insurance could experience a decline.

PL Capital noted that private life insurers recorded approximately 13 percent year on year growth in July and August, supported by improving demand for unit linked and non participating products, strong annuity demand and continued traction in protection policies. The brokerage expects margins to improve sequentially as the product mix becomes more favourable, although the exemption of life insurance premiums from goods and services tax could weigh on profitability.

Systematix expects new business premium growth across the life insurance industry to remain healthy at approximately 17 to 18 percent year on year, driven by protection, non participating savings and annuity products. It expects LIC, HDFC Life and ICICI Prudential Life to deliver among the strongest new business premium growth rates within its coverage universe. Unlike Emkay, Systematix has identified SBI Life as its preferred stock in the life insurance segment.

The outlook for general insurers remains more challenging because of aggressive pricing in commercial insurance, competition in motor insurance and weather related claims. Emkay Research expects ICICI Lombard General Insurance’s gross written premium to decline 1.1 percent year on year to Rs 6,980 crore during the September quarter. Its claims ratio is projected to increase to 73.3 percent, while net profit is expected to decline 1.4 percent to Rs 808 crore.

Go Digit General Insurance is projected to report an approximately 1 percent decline in gross written premium, with net profit expected to fall 23.7 percent to Rs 89 crore. Flood related claims and competitive pressures in commercial and motor insurance are among the factors influencing its earnings outlook.

However, premium growth trends indicate continued strength in health insurance. Motilal Oswal reported that general insurance premiums grew 6 percent year on year in July and 10 percent in August. Health insurance premiums increased 26 percent and 18 percent, respectively, while motor insurance maintained growth of approximately 10 to 14 percent. Sustained demand for health coverage and stable motor insurance premiums could provide support to the broader general insurance industry, although regulatory changes could affect distribution costs and profitability.

Standalone health insurer Star Health and Allied Insurance is expected to benefit from continued growth in health insurance demand. Emkay projects its gross written premium to rise 19 percent to Rs 5,264 crore, while insurance revenue is expected to increase 15.3 percent to Rs 5,109 crore. Its claims ratio is projected to improve to 69.8 percent, and net profit is expected to grow 56 percent to Rs 124 crore.

Regulatory uncertainty remains a common concern across the insurance industry. The proposed changes to commission structures and expense of management limits could alter the economics of insurance distribution and affect insurers, brokers and other intermediaries differently. Motilal Oswal highlighted the possibility of near term uncertainty for distributors, while PL Capital identified the proposed guidelines as an important monitorable amid corrections in insurance sector valuations.

Investors are expected to focus on premium growth, product mix, claims management, operating efficiency and the potential impact of regulatory changes on profitability. Emkay retained buy ratings on HDFC Life Insurance, SBI Life Insurance and LIC, while maintaining add ratings on ICICI Prudential Life Insurance and Max Financial Services. However, it reduced its target prices for HDFC Life to Rs 700, ICICI Prudential Life to Rs 550, Max Financial Services to Rs 1,700 and SBI Life to Rs 2,150. LIC’s target price remained unchanged at Rs 550.

Within general insurance, Emkay maintained an add rating on ICICI Lombard General Insurance with a target price of Rs 1,900 and a buy rating on Star Health and Allied Insurance with a target price of Rs 700. It retained a reduce rating on Go Digit General Insurance with a target price of Rs 270. Overall, the September quarter outlook suggests that product mix and new business growth could support selected life insurers, while claims experience, competitive pricing and regulatory developments will remain critical determinants of profitability across the insurance sector.